Elekta

Report Publication Announcement • Sep 27, 2012

Press release Stockholm, September 27, 2012

Welcome to Elekta Capital Markets Day at ASTRO, Boston, October 29, 2012

Elekta would like to welcome you to a Capital Markets Day in conjunction with the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Boston, USA.

The event will be held on Monday, October 29, at 1.00 pm – 3.00 pm local time, at Sheraton Boston Hotel.

Elekta's President and CEO Tomas Puusepp, together with other members of Elekta's Management Team will present the company with a focus on the product portfolio and solutions.

It will also be possible to listen to the presentations via the web and by telephone. Please use the following link: http://webeventservices.reg.meetingstream.com/elekta\_69713 or use the telephone numbers below and the access code 923117.

• Swedish dial-in number: +46 (0)8 5052 0110
• UK dial-in number: +44 (0)20 7162 0077
• US dial-in number: +1 334 323 6201

Investors who want to attend the Capital Market Day are kindly requested to give notice by e-mail to elisabeth.natt.och.dag@elekta.com before October 19.

Additional Elekta events at ASTRO

Investors are also welcome to participate in:

• The Elekta Oncology Users Meeting held on Saturday, October 27, at 7.30 am 4.00 pm, at Hynes Convention Center. To register please use this link: https://www.cvent.com/events/21st-elekta-oncology-users-meeting/registrationd8f0f4036dcb4842b484dd88a62f0a9c.aspx
• A guided Elekta Booth Tour arranged on Tuesday, October 30, starting at 11.00 am. Investors who want to attend the Booth Tour are kindly requested to give notice by e-mail to elisabeth.natt.och.dag@elekta.com before October 19.

For further information, please contact:

Elisabeth Natt och Dag, Information Manager, Elekta AB Tel: +46 733 16 16 88, e-mail: elisabeth.natt.och.dag@elekta.com

Johan Andersson Melbi, Investor Relations Manager, Elekta AB Tel: +46 702 100 451, e-mail: johan.anderssonmelbi@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.